Cargando…
Rationally designed Ru(ii)-metallacycle chemo-phototheranostic that emits beyond 1000 nm
Ruthenium complexes are emerging as potential complements to platinum drugs. They also show promise as photo-diagnostic and therapeutic agents. However, most ruthenium species studied to date as potential drugs are characterized by short excitation/emission wavelengths. This limits their applicabili...
Autores principales: | Li, Chonglu, Xu, Yuling, Tu, Le, Choi, Minhyeok, Fan, Yifan, Chen, Xiaoqiang, Sessler, Jonathan L., Kim, Jong Seung, Sun, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172562/ https://www.ncbi.nlm.nih.gov/pubmed/35756528 http://dx.doi.org/10.1039/d2sc01518h |
Ejemplares similares
-
Construction of emissive ruthenium(II) metallacycle over 1000 nm wavelength for in vivo biomedical applications
por: Xu, Yuling, et al.
Publicado: (2022) -
Long wavelength–emissive Ru(II) metallacycle–based photosensitizer assisting in vivo bacterial diagnosis and antibacterial treatment
por: Xu, Yuling, et al.
Publicado: (2022) -
Rational design of an “all-in-one” phototheranostic
por: Yang, Zi-Shu, et al.
Publicado: (2020) -
Acceptor engineering of metallacycles with high phototoxicity indices for safe and effective photodynamic therapy
por: Li, Chonglu, et al.
Publicado: (2023) -
Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy
por: Lin, Xiongjie, et al.
Publicado: (2022)